Benchmark of 10 public tools finds antimicrobial peptide MIC predictors more useful for ranking than for exact values
US-MadeSince 2022>99% HPLC purityLab COA per batchFedEx 2-DayFree shipping on $200+

Research community

Benchmark of 10 public tools finds antimicrobial peptide MIC predictors more useful for ranking than for exact values

Researchers at Hunan Normal University in China reported in Small Methods, published online on 15 October, a retrospective benchmark of 10 publicly released tools that predict the minimum inhibitory concentration (MIC) of antimicrobial peptides (AMPs) directly from sequence.

  • news
  • 2026-10-17
  • trends
Stick and ribbon render of the beta-hairpin antimicrobial peptide protegrin-1 (PDB 1PG1)
Image: BioLabs Research, rendered from PDB 1PG1 (RCSB PDB, CC0)

Summary. Researchers at Hunan Normal University in China reported in Small Methods, published online on 15 October, a retrospective benchmark of 10 publicly released tools that predict the minimum inhibitory concentration (MIC) of antimicrobial peptides (AMPs) directly from sequence. Such quantitative models, spanning classical machine learning and more recent deep learning, are increasingly used to prioritise candidate sequences before synthesis. The group ran each tool out of the box on an external dataset of newly reported AMPs with measured activity and on reconstructed versions of the tools' own native datasets, scoring absolute MIC regression, reproducibility, directional prediction patterns, ranking and virtual-screening enrichment.

Stick and ribbon render of the antimicrobial peptide magainin 2 (PDB 2MAG)
Credit: Image: BioLabs Research, rendered from PDB 2MAG (RCSB PDB, CC0)

Research context (RUO). The authors report that most released tools showed poor absolute MIC regression and limited transfer to the external benchmark, although selected tools kept useful relative-ranking and enrichment ability. Re-running the published implementations also revealed marked differences in how reproducibly they could be executed. Error-stratified analyses linked prediction errors to peptide residue composition and showed a general compression of the predicted activity range. The evaluated tools are listed with their public code repositories, and the new benchmark data are provided as supplementary files. The study is computational and makes no biological or clinical claims. The authors conclude that current quantitative AMP predictors are best used as early-stage screening filters rather than as substitutes for experimental MIC measurement. For peptide-design and microbiology laboratories, the paper is a practical reference for choosing and validating such tools.

Stick and ribbon render of the helical antimicrobial peptide LL-37 (PDB 2K6O)
Credit: Image: BioLabs Research, rendered from PDB 2K6O (RCSB PDB, CC0)